UFP Technologies, Inc. (UFPT) Gross Margin
- Gross margin · 12 months: Value 28.50%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 28.50% | Gross profit / revenue. Period ending 2026-06-30. $180.00M ÷ $631.64M × 100 ≈ 28.50% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 180.00M USD | Gross Profit |
| Revenue | 631.64M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 451.64M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $180.00M | $631.64M | $451.64M | 28.50% |
| 2026-03-31 | $172.62M | $608.85M | $436.23M | 28.35% |
| 2025-12-31 | $170.41M | $602.80M | $432.39M | 28.27% |
| 2025-09-30 | $170.50M | (m) | $427.45M | (m) |
| 2025-06-30 | $169.27M | (m) | $419.29M | (m) |
| 2025-03-31 | $158.76M | (m) | $388.80M | (m) |
| 2024-12-31 | $146.69M | (m) | $357.73M | (m) |
| 2024-09-30 | $130.77M | (m) | $331.08M | (m) |
| 2024-06-30 | $116.99M | (m) | $300.48M | (m) |
| 2024-03-31 | $113.61M | (m) | $293.72M | (m) |
| 2023-12-31 | $112.22M | (m) | $287.85M | (m) |
| 2023-09-30 | $109.38M | (m) | $280.44M | (m) |
| 2023-06-30 | $107.15M | (m) | $278.85M | (m) |
| 2023-03-31 | $101.83M | (m) | $278.48M | (m) |
| 2022-12-31 | $90.26M | (m) | $263.53M | (m) |
| 2022-09-30 | $80.06M | (m) | $238.84M | (m) |
| 2022-06-30 | $66.55M | (m) | $206.10M | (m) |
| 2022-03-31 | $55.64M | (m) | $173.32M | (m) |
| 2021-12-31 | $51.11M | (m) | $155.21M | (m) |
| 2021-09-30 | $49.42M | (m) | $145.71M | (m) |
| 2021-06-30 | $47.93M | (m) | $139.77M | (m) |
| 2021-03-31 | $44.47M | (m) | $135.22M | (m) |
| 2020-12-31 | $44.68M | (m) | $134.69M | (m) |
| 2020-09-30 | $47.07M | (m) | $137.41M | (m) |
| 2020-06-30 | $49.87M | (m) | $140.71M | (m) |
| 2020-03-31 | $54.28M | (m) | $145.04M | (m) |
| 2019-12-31 | $53.96M | (m) | $144.42M | (m) |
| 2019-09-30 | $52.89M | (m) | $145.92M | (m) |
| 2019-06-30 | $52.01M | (m) | $145.23M | (m) |
| 2019-03-31 | $50.62M | (m) | $144.23M | (m) |
| 2018-12-31 | $48.31M | (m) | $142.15M | (m) |
| 2018-09-30 | $43.44M | (m) | (m) | (m) |
| 2018-06-30 | $39.20M | (m) | (m) | (m) |
| 2018-03-31 | $36.16M | (m) | (m) | (m) |
| 2017-12-31 | $35.49M | $147.84M | (m) | 24.00% |
| 2017-09-30 | $35.84M | $147.13M | (m) | 24.36% |
| 2017-06-30 | $36.09M | $148.66M | (m) | 24.28% |
| 2017-03-31 | $36.44M | $148.68M | (m) | 24.51% |
| 2016-12-31 | $34.65M | $146.13M | (m) | 23.71% |
| 2016-09-30 | $35.48M | $143.56M | (m) | 24.71% |
| 2016-06-30 | $36.54M | $140.78M | (m) | 25.96% |
| 2016-03-31 | $36.54M | $139.38M | (m) | 26.22% |
| 2015-12-31 | $37.45M | $138.85M | (m) | 26.97% |
| 2015-09-30 | $36.85M | $140.18M | (m) | 26.29% |
| 2015-06-30 | $37.09M | $141.15M | (m) | 26.28% |
| 2015-03-31 | $36.34M | $138.68M | (m) | 26.21% |
| 2014-12-31 | $36.88M | $139.31M | (m) | 26.47% |
| 2014-09-30 | $39.13M | $139.03M | (m) | 28.15% |
| 2014-06-30 | $39.61M | $138.33M | (m) | 28.64% |
| 2014-03-31 | $40.78M | $140.13M | (m) | 29.10% |
| 2013-12-31 | $40.65M | $139.22M | (m) | 29.20% |
| 2013-09-30 | $39.85M | $137.60M | (m) | 28.96% |
| 2013-06-30 | $38.91M | $134.87M | (m) | 28.85% |
| 2013-03-31 | $37.89M | $132.71M | (m) | 28.55% |
| 2012-12-31 | $38.19M | $130.96M | (m) | 29.16% |
| 2012-09-30 | $37.07M | $129.07M | (m) | 28.72% |
| 2012-06-30 | $36.33M | $127.86M | (m) | 28.41% |
| 2012-03-31 | $36.64M | $127.69M | (m) | 28.70% |
| 2011-12-31 | $36.24M | $127.24M | (m) | 28.48% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $34.62M | $120.77M | (m) | 28.66% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $26.72M | $99.23M | (m) | 26.93% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |